- Home
- CFFI vs BDTX Comparison
CFFI vs BDTX Comparison
Compare CFFI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- BDTX
- Stock Information
- Founded
- CFFI 1927
- BDTX 2014
- Country
- CFFI United States
- BDTX United States
- Employees
- CFFI N/A
- BDTX N/A
- Industry
- CFFI Major Banks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFFI Finance
- BDTX Health Care
- Exchange
- CFFI Nasdaq
- BDTX Nasdaq
- Market Cap
- CFFI 218.0M
- BDTX 181.4M
- IPO Year
- CFFI 1998
- BDTX 2020
- Fundamental
- Price
- CFFI $71.30
- BDTX $2.94
- Analyst Decision
- CFFI
- BDTX Strong Buy
- Analyst Count
- CFFI 0
- BDTX 6
- Target Price
- CFFI N/A
- BDTX $12.50
- AVG Volume (30 Days)
- CFFI 10.8K
- BDTX 802.5K
- Earning Date
- CFFI 10-28-2025
- BDTX 11-04-2025
- Dividend Yield
- CFFI 2.58%
- BDTX N/A
- EPS Growth
- CFFI 32.15
- BDTX N/A
- EPS
- CFFI 7.56
- BDTX 0.25
- Revenue
- CFFI $122,075,000.00
- BDTX $70,000,000.00
- Revenue This Year
- CFFI N/A
- BDTX N/A
- Revenue Next Year
- CFFI N/A
- BDTX N/A
- P/E Ratio
- CFFI $9.43
- BDTX $11.74
- Revenue Growth
- CFFI 7.42
- BDTX N/A
- 52 Week Low
- CFFI $53.14
- BDTX $1.20
- 52 Week High
- CFFI $89.90
- BDTX $6.33
- Technical
- Relative Strength Index (RSI)
- CFFI 59.21
- BDTX 57.58
- Support Level
- CFFI $69.47
- BDTX $2.56
- Resistance Level
- CFFI $71.98
- BDTX $2.95
- Average True Range (ATR)
- CFFI 1.89
- BDTX 0.16
- MACD
- CFFI 0.10
- BDTX 0.02
- Stochastic Oscillator
- CFFI 72.09
- BDTX 79.00
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.